Glutathione and cysteine levels in human tumour biopsies. 1990

M Guichard, and F Lespinasse, and R Estelin, and A Gerbaulet, and C Haie, and E Lartigau, and E P Malaise, and C Micheau, and M Prade, and J M Richard
Laboratoire de Radiobiologie Cellulaire (Unité Inserm 247), Institut Gustave-Roussy, Villejuif, France.

There is evidence that some human tumours could be treated with a combination of buthionine sulfoximine and hypoxic cell sensitizers. However, clinical application of this technique requires a prior knowledge of the level of non-protein bound sulfhydryl (NPSH) compounds in these tumours. The present study provides data on the levels of glutathione (GSH) and cysteine (CYS) in human tumour biopsies from the cervix and from the head and neck. The NPSH compounds were measured by high performance liquid chromatography. The median GSH values were 20.5 nmol/mg protein (cervix) and 23 nmol/mg protein (head and neck) while the median CYS values were 4.4 (cervix) and 4.2 nmol/mg protein (head and neck). The values varied widely from one patient to another.

UI MeSH Term Description Entries
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003545 Cysteine A thiol-containing non-essential amino acid that is oxidized to form CYSTINE. Cysteine Hydrochloride,Half-Cystine,L-Cysteine,Zinc Cysteinate,Half Cystine,L Cysteine
D005260 Female Females
D005978 Glutathione A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides. Reduced Glutathione,gamma-L-Glu-L-Cys-Gly,gamma-L-Glutamyl-L-Cysteinylglycine,Glutathione, Reduced,gamma L Glu L Cys Gly,gamma L Glutamyl L Cysteinylglycine
D006258 Head and Neck Neoplasms Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651) Cancer of Head and Neck,Head Cancer,Head Neoplasm,Head and Neck Cancer,Head and Neck Neoplasm,Neck Cancer,Neck Neoplasm,Neck Neoplasms,Neoplasms, Upper Aerodigestive Tract,UADT Neoplasm,Upper Aerodigestive Tract Neoplasm,Upper Aerodigestive Tract Neoplasms,Cancer of Head,Cancer of Neck,Cancer of the Head,Cancer of the Head and Neck,Cancer of the Neck,Head Neoplasms,Head, Neck Neoplasms,Neoplasms, Head,Neoplasms, Head and Neck,Neoplasms, Neck,UADT Neoplasms,Cancer, Head,Cancer, Neck,Cancers, Head,Cancers, Neck,Head Cancers,Neck Cancers,Neoplasm, Head,Neoplasm, Neck,Neoplasm, UADT,Neoplasms, UADT
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

M Guichard, and F Lespinasse, and R Estelin, and A Gerbaulet, and C Haie, and E Lartigau, and E P Malaise, and C Micheau, and M Prade, and J M Richard
January 1990, Journal of dermatological science,
M Guichard, and F Lespinasse, and R Estelin, and A Gerbaulet, and C Haie, and E Lartigau, and E P Malaise, and C Micheau, and M Prade, and J M Richard
September 2004, Nutrition (Burbank, Los Angeles County, Calif.),
M Guichard, and F Lespinasse, and R Estelin, and A Gerbaulet, and C Haie, and E Lartigau, and E P Malaise, and C Micheau, and M Prade, and J M Richard
November 1987, Pediatric research,
M Guichard, and F Lespinasse, and R Estelin, and A Gerbaulet, and C Haie, and E Lartigau, and E P Malaise, and C Micheau, and M Prade, and J M Richard
June 1976, Clinical oncology,
M Guichard, and F Lespinasse, and R Estelin, and A Gerbaulet, and C Haie, and E Lartigau, and E P Malaise, and C Micheau, and M Prade, and J M Richard
April 1985, European journal of pharmacology,
M Guichard, and F Lespinasse, and R Estelin, and A Gerbaulet, and C Haie, and E Lartigau, and E P Malaise, and C Micheau, and M Prade, and J M Richard
February 1991, Biochemical pharmacology,
M Guichard, and F Lespinasse, and R Estelin, and A Gerbaulet, and C Haie, and E Lartigau, and E P Malaise, and C Micheau, and M Prade, and J M Richard
December 2012, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals,
M Guichard, and F Lespinasse, and R Estelin, and A Gerbaulet, and C Haie, and E Lartigau, and E P Malaise, and C Micheau, and M Prade, and J M Richard
March 1990, Carcinogenesis,
M Guichard, and F Lespinasse, and R Estelin, and A Gerbaulet, and C Haie, and E Lartigau, and E P Malaise, and C Micheau, and M Prade, and J M Richard
October 2003, Digestive diseases and sciences,
M Guichard, and F Lespinasse, and R Estelin, and A Gerbaulet, and C Haie, and E Lartigau, and E P Malaise, and C Micheau, and M Prade, and J M Richard
October 2007, The American journal of clinical nutrition,
Copied contents to your clipboard!